My understanding was that this was for SleepCheck with ResAppDx resubmission even further down the line. I'm certain that they have a decent amount of real world usability data for both products, but the consultants are probably pushing them to the more conservative route of more formal and controlled usability study. All just my speculation.
- Forums
- ASX - By Stock
- RAP
- Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic
Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-206
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)